Cargando…
GDI2 is a novel diagnostic and prognostic biomarker in hepatocellular carcinoma
Background: GDP Dissociation inhibitor 2 (GDI2) gene has been correlated with some important biological processes in a variety of cancers, whereas the role of GDI2 in hepatocellular carcinoma (HCC) is ill-defined. We aimed to demonstrate the relationship between GDI2 and HCC based on The Cancer Geno...
Autores principales: | Zhang, Wen, Liu, Zhongjian, Xia, Shilin, Yao, Lei, Li, Lan, Gan, Ziying, Tang, Hui, Guo, Qiang, Yan, Xinmin, Sun, Zhiwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714169/ https://www.ncbi.nlm.nih.gov/pubmed/34894398 http://dx.doi.org/10.18632/aging.203748 |
Ejemplares similares
-
A novel seven-gene signature as Prognostic Biomarker in Hepatocellular Carcinoma
por: Xie, Hui, et al.
Publicado: (2020) -
APEX1 is a novel diagnostic and prognostic biomarker for hepatocellular carcinoma
por: Cao, Lei, et al.
Publicado: (2020) -
Graphics programming with GDI
por: Chand, Mahesh
Publicado: (2004) -
Value of KPNA4 as a diagnostic and prognostic biomarker for hepatocellular carcinoma
por: Xu, Mingxing, et al.
Publicado: (2021) -
miR-25 promotes hepatocellular carcinoma cell growth, migration and invasion by inhibiting RhoGDI1
por: Wang, Congren, et al.
Publicado: (2015)